Metraipolis › archive › dc_a8ee60749305
The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease — Europe PMC PMID:41479572
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41479572
- DOI
- 10.32607/actanaturae.27808
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T15:46:49.414Z
- SHA-256 of the archived text
e260c1dabb6e727d91bbaf36441d14c6fee0f7414159a1ebda7248e161d01501- Stable URL of this page
https://metraipolis.com/documento/dc_a8ee60749305
How to cite
The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease — Europe PMC PMID:41479572 — Europe PMC (en), https://europepmc.org/article/MED/41479572 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a8ee60749305 (Metraipolis archive dc_a8ee60749305, sha256 e260c1dabb6e727d91bbaf36441d14c6fee0f7414159a1ebda7248e161d01501)
BibTeX
@misc{dca8ee60749305,
title = {The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease — Europe PMC PMID:41479572},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41479572},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a8ee60749305; sha256 e260c1dabb6e727d91bbaf36441d14c6fee0f7414159a1ebda7248e161d01501},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41479572. Agents can read the archived copy with the MCP tool read_document.